Stock Based Compensation - Omnibus Incentive Plan (Details) - Omnibus Plan - Stock Options - $ / shares		9 Months Ended		12 Months Ended
	May 27, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Stock based compensation
Number of additional shares authorized	1,000,000
Number of shares available for grant	2,200,000	879,197
Stock options granted (in shares)		44,905	115,659
Number of shares
Balance at beginning of year (in shares)		778,835
Granted (in shares)		44,905	115,659
Exercised (in shares)		(18,186)
Expired (in shares)		(1,320)
Forfeited (in shares)		(10,457)
Balance at end of year (in shares)		793,777		778,835
Options: Options vested and exercisable		684,927
Options: Options vested and expected to vest		793,777
Weighted-Average Exercise Price
Balance at beginning of year (in dollars per share)		$ 18.02
Granted (in dollars per share)		14.95
Exercised (in dollars per share)		4.31
Expired (in dollars per share)		21.75
Forfeited (in dollars per share)		28.03
Balance at end of year (in dollars per share)		18.02		$ 18.02
Weighted-Average Exercise Price: Options vested and exercisable		17.12
Weighted-Average Exercise Price: Options vested and expected to vest		$ 18.02
Weighted- Average Remaining Contractual Term (in Years)
Balance (in years)		4 years 11 months 1 day		5 years 7 months 2 days
Granted (in years)		6 years 5 months 19 days
Weighted-Average Remaining Contractual Term (in Years): Options vested and exercisable		4 years 8 months 15 days
Weighted-Average Remaining Contractual Term (in Years): Options vested and expected to vest		4 years 11 months 1 day
Number of unvested options scheduled to vest
Non-Vested Options as of beginning of period		127,357
Granted (in shares)		44,905	115,659
Vested (in shares)		(52,955)
Forfeited (in shares)		(10,457)
Non-Vested Options as of end of period		108,850		127,357
Weighted-Average Grant Date Fair Value
Non-Vested, beginning balance		$ 17.42
Granted: Weighted-Average Grant Date Fair Value		8.99
Vested: Weighted-Average Grant Date Fair Value		17.43
Forfeited: Weighted-Average Grant Date Fair Value		16.52
Non-Vested, ending balance		$ 14.03		$ 17.42
Valuation Assumptions:
Expected term in years		4 years 3 months 18 days	4 years 3 months 18 days
Volatility (as a percent)		77.60%	78.60%
Risk-free interest rate		2.90%	0.70%
Dividend yield (as a percent)		0.00%
Granted: Weighted-Average Grant Date Fair Value		$ 8.99
2022
Number of unvested options scheduled to vest
Non-Vested Options as of end of period		108,850
Valuation Assumptions:
Term of award		P7Y
Vesting period		2 years